Wiggins, B.T.; Ramirez, D.; Taylor, D.; Reichardt, W.; Kipke, A.; Minaudo, M.
Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy. Hematol. Rep. 2022, 14, 290-293.
https://doi.org/10.3390/hematolrep14040041
AMA Style
Wiggins BT, Ramirez D, Taylor D, Reichardt W, Kipke A, Minaudo M.
Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy. Hematology Reports. 2022; 14(4):290-293.
https://doi.org/10.3390/hematolrep14040041
Chicago/Turabian Style
Wiggins, Brandon Travis, Daniel Ramirez, Daniel Taylor, William Reichardt, Alyssa Kipke, and Mark Minaudo.
2022. "Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy" Hematology Reports 14, no. 4: 290-293.
https://doi.org/10.3390/hematolrep14040041
APA Style
Wiggins, B. T., Ramirez, D., Taylor, D., Reichardt, W., Kipke, A., & Minaudo, M.
(2022). Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy. Hematology Reports, 14(4), 290-293.
https://doi.org/10.3390/hematolrep14040041